Connes P, Monchanin G, Perrey S, Wouassi D, Atchou G, Forsuh A, Debaud J, Djoda B, Owona F-X, Francina A, Banga P E, Massarelli R, Thiriet P, Martin C
EA 647 Centre de Recherche et d'Innovation sur le Sport, Université Claude Bernard Lyon 1, Villeurbanne, France.
Int J Sports Med. 2006 Jul;27(7):517-25. doi: 10.1055/s-2005-865823.
Sickle cell trait (SCT) is a genetic disease affecting the synthesis of normal hemoglobin (Hb) marked by the heterozygous presence of HbA and HbS. It is thought that exercise tolerance and aerobic capacity could be limited in SCT carriers, but that the co-existence of alpha-thalassemia with SCT (SCTAT) could improve exercise response. To examine these issues, we compared the characteristics of VO2 kinetics during a constant heavy exercise among athletes carrying either the SCT (n = 6), the SCTAT (n = 9), or the normal Hb (control group; n = 10). After determination of maximal power output (Ppeak), all subjects underwent a constant heavy cycling exercise lasting 9 min at approximately 70 % Ppeak. Pulmonary VO2 and cardio-respiratory parameters were measured breath-by-breath and the VO2 response was modelled using non-linear regression techniques. The time constant of the VO2 primary component and oxygen deficit were not significantly different among the three groups. The VO2 slow component was 28 % and 33 % higher (p < 0.05) in SCT and SCTAT than in the control groups, respectively. Altogether, athletes with the SCT and the SCTAT had higher heart rate at the beginning (+ 5.2 %) and the end (+ 7.4 %) of the slow component compared to the control group (p < 0.05). These results suggest that SCT and SCTAT subjects are not limited during the first exercise minutes, but are prone to exercise intolerance and to lower aerobic capacity thereafter, due to a higher VO2 slow component, and that alpha-thalassemia does not improve exercise response. The finding of a higher slow component in SCT and SCTAT athletes was possibly due to the loss of O2 availability to muscles, additional fiber recruitment and/or higher cardiac load with time.
镰状细胞性状(SCT)是一种影响正常血红蛋白(Hb)合成的遗传性疾病,其特征是杂合存在HbA和HbS。人们认为,SCT携带者的运动耐力和有氧能力可能会受到限制,但α地中海贫血与SCT(SCTAT)共存可能会改善运动反应。为了研究这些问题,我们比较了携带SCT(n = 6)、SCTAT(n = 9)或正常Hb(对照组;n = 10)的运动员在持续剧烈运动期间的VO2动力学特征。在确定最大功率输出(Ppeak)后,所有受试者在约70%Ppeak的强度下进行了持续9分钟的剧烈循环运动。逐次测量肺VO2和心肺参数,并使用非线性回归技术对VO2反应进行建模。三组之间VO2主要成分的时间常数和氧亏无显著差异。SCT组和SCTAT组的VO2慢成分分别比对照组高28%和33%(p < 0.05)。总体而言,与对照组相比,SCT组和SCTAT组的运动员在慢成分开始时(+ 5.2%)和结束时(+ 7.4%)的心率更高(p < 0.05)。这些结果表明,SCT和SCTAT受试者在运动的前几分钟不受限,但由于VO2慢成分较高,随后容易出现运动不耐受和有氧能力降低,并且α地中海贫血不会改善运动反应。SCT和SCTAT运动员中慢成分较高的发现可能是由于肌肉氧气供应减少、额外的纤维募集和/或随着时间推移心脏负荷增加。